It also significantly, though modestly, improved endothelium-dependent vasodilatation, which is likely consequent to a reduction in hypercontractility that is associated with attenuation of VSMC NOX activity.
For instance, MMP9-deficient mice showed modestly reduced experience-dependent plasticity in the barrel cortex (Kaliszewska et al., 2012) and MMP3-deficient mice displayed abnormal neuronal morphology in the visual cortex and impaired plasticity induced by long-term monocular enucleation (Aerts et al., 2014).
In model 3 (fully adjusted model), addition of time-dependent stroke modestly decreased the HR for treated diabetes by 9% and untreated diabetes by 10%, but the association with treated diabetes remained strong and statistically significant.
Endothelium-dependent vasodilatation was modestly yet significantly improved which was accompanied by AG-dependent significant reduction in aortic hypercontractility.
Thus, the levels of both of these RAP-dependent receptors were modestly reduced in mice partially deficient in RAP.
However, given that a β receptor agonist unlikely causes overphosphorylation of the R domain, it may only modestly counteract the SMase C-dependent suppression of CFTR current.
Similarly, EFNA3 was induced by Th1 cytokines, albeit modestly, in a HIF-1-dependent manner, with IL-1β exerting an additive effect on EFNA3 expression in hypoxia.
In line, the present study demonstrated that PON1 activity is primarily genotype dependent, and is just modestly influenced by plasma vitamin C concentration.
However, in combination with erlotinib, two Class 4 compounds modestly but significantly enhanced the erlotinib-dependent decrease in cell viability.
The endothelium-dependent vasodilatation however was modestly but significantly improved by AG, likely consequent to AG-induced reduction in hyper-contractility.
